News
Feed
Events
Feed
News
+ Events
Feed

Proteros biostructures GmbH

  • Land Deutschland

Aktuelle News

6 September 2023

10:00 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros biostructures and Orion Pharma agree on long-term multi-target collaboration including assembly of a joint novel and unique HTS small-molecule library with full chemistry support of Enamine

9 Januar 2023

10:00 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros receives minority investment from private equity firm Inflexion

25 Oktober 2022

10:00 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases

28 November 2019

09:00 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros, co-founder of Rodin Therapeutics, announces Rodin’s acquisition by Alkermes

6 Dezember 2017

09:00 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros biostructures GmbH names Dave Lemus as new executive board member

27 Juli 2017

10:00 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros enters into new research collaboration with Johnson & Johnson Innovation on sub-class of epigenetic targets

23 November 2015

09:00 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros biostructures GmbH: 23rd Conference on Protein Structure Determination in Industry (PSDI) discussing important impact of structural biology for drug discovery

7 Oktober 2015

09:00 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros signs new oncology collaboration with Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA on epigenetic target

29 Juni 2015

09:00 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros Appoints Dr. Torsten Hoffmann as Chief Scientific Officer

18 Mai 2015

09:00 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros Achieves Key Milestone in Janssen Lead Discovery Collaboration

8 Januar 2015

09:00 Corporate

Proteros biostructures GmbH

Corporate

Proteros geht Kooperation mit Bayer zur Entwicklung neuer kardiovaskulärer Wirkstoffe für integrales Membranprotein ein

29 Mai 2014

15:19 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Update of release from 29.05.2014, 13:29 CET: Proteros announces a USD 12.9 million Series A Financing of Rodin Therapeutics

13:29 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros announces a USD 12 million Series A Financing of Rodin Therapeutics, a Company founded by Atlas Venture and Proteros, Focussing on Novel Treatments for CNS Disorders

12 Mai 2014

09:32 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros biostructures GmbH: Proteros Announces Changes in Management Team

20 Februar 2014

08:00 Corporate EN

Proteros biostructures GmbH

Corporate
EN

Proteros biostructures GmbH Announces Election of Prof. Eric-Paul Pâques, CEO of Grünenthal, as New Supervisory Board Member

Anstehende Events

Keine Events gefunden